ID   SOX10_RAT               Reviewed;         466 AA.
AC   O55170;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=Transcription factor SOX-10;
GN   Name=Sox10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9412504; DOI=10.1523/jneurosci.18-01-00237.1998;
RA   Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., Wegner M.;
RT   "Sox10, a novel transcriptional modulator in glial cells.";
RL   J. Neurosci. 18:237-250(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=26525805; DOI=10.1111/jnc.13414;
RA   Baroti T., Schillinger A., Wegner M., Stolt C.C.;
RT   "Sox13 functionally complements the related Sox5 and Sox6 as important
RT   developmental modulators in mouse spinal cord oligodendrocytes.";
RL   J. Neurochem. 136:316-328(2016).
CC   -!- FUNCTION: Transcription factor that plays a central role in developing
CC       and mature glia (By similarity). Specifically activates expression of
CC       myelin genes, during oligodendrocyte (OL) maturation, such as DUSP15
CC       and MYRF, thereby playing a central role in oligodendrocyte maturation
CC       and CNS myelination (By similarity). Once induced, MYRF cooperates with
CC       SOX10 to implement the myelination program (By similarity).
CC       Transcriptional activator of MITF, acting synergistically with PAX3 (By
CC       similarity). Transcriptional activator of MBP, via binding to the gene
CC       promoter (PubMed:26525805). {ECO:0000250|UniProtKB:P56693,
CC       ECO:0000250|UniProtKB:Q04888, ECO:0000269|PubMed:26525805}.
CC   -!- SUBUNIT: Monomer. Interacts with Armcx3 at the mitochondrial outer
CC       membrane surface. Interacts with PAX3 (By similarity).
CC       {ECO:0000250|UniProtKB:P56693, ECO:0000250|UniProtKB:Q04888}.
CC   -!- INTERACTION:
CC       O55170; Q13287: NMI; Xeno; NbExp=4; IntAct=EBI-1185693, EBI-372942;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q04888}. Nucleus
CC       {ECO:0000269|PubMed:9412504}. Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:Q04888}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q04888}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q04888}.
CC   -!- TISSUE SPECIFICITY: Predominant expression in glial cells of the
CC       nervous system. {ECO:0000269|PubMed:9412504}.
CC   -!- DOMAIN: The transactivation domains TAM and TAC (for transactivation
CC       domain in the middle and at the C-terminus, respectively) are required
CC       to contact transcriptional coactivators and basal transcriptional
CC       machinery components and thereby induce gene transactivation.
CC       {ECO:0000250|UniProtKB:P48436}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ001029; CAA04485.1; -; mRNA.
DR   EMBL; BC062067; AAH62067.1; -; mRNA.
DR   RefSeq; NP_062066.1; NM_019193.2.
DR   RefSeq; XP_017450187.1; XM_017594698.1.
DR   AlphaFoldDB; O55170; -.
DR   SMR; O55170; -.
DR   BioGRID; 248015; 17.
DR   IntAct; O55170; 2.
DR   MINT; O55170; -.
DR   STRING; 10116.ENSRNOP00000015283; -.
DR   iPTMnet; O55170; -.
DR   PhosphoSitePlus; O55170; -.
DR   PaxDb; 10116-ENSRNOP00000015283; -.
DR   Ensembl; ENSRNOT00000015283.4; ENSRNOP00000015283.3; ENSRNOG00000011305.4.
DR   Ensembl; ENSRNOT00055054279; ENSRNOP00055044884; ENSRNOG00055031334.
DR   Ensembl; ENSRNOT00060032911; ENSRNOP00060026908; ENSRNOG00060019038.
DR   Ensembl; ENSRNOT00065056930; ENSRNOP00065046871; ENSRNOG00065033091.
DR   GeneID; 29361; -.
DR   KEGG; rno:29361; -.
DR   UCSC; RGD:3735; rat.
DR   AGR; RGD:3735; -.
DR   CTD; 6663; -.
DR   RGD; 3735; Sox10.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000158046; -.
DR   HOGENOM; CLU_031800_0_0_1; -.
DR   InParanoid; O55170; -.
DR   OMA; ATIQAHY; -.
DR   OrthoDB; 2902801at2759; -.
DR   PhylomeDB; O55170; -.
DR   Reactome; R-RNO-9856649; Transcriptional and post-translational regulation of MITF-M expression and activity.
DR   PRO; PR:O55170; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000011305; Expressed in cerebellum and 11 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IMP:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0048468; P:cell development; NAS:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0048469; P:cell maturation; ISO:RGD.
DR   GO; GO:0071393; P:cellular response to progesterone stimulus; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0022010; P:central nervous system myelination; ISS:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; ISO:RGD.
DR   GO; GO:0048546; P:digestive tract morphogenesis; ISO:RGD.
DR   GO; GO:0048484; P:enteric nervous system development; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0032808; P:lacrimal gland development; ISO:RGD.
DR   GO; GO:0030318; P:melanocyte differentiation; ISO:RGD.
DR   GO; GO:0061138; P:morphogenesis of a branching epithelium; ISO:RGD.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010626; P:negative regulation of Schwann cell proliferation; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0001755; P:neural crest cell migration; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0014003; P:oligodendrocyte development; ISS:UniProtKB.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0007422; P:peripheral nervous system development; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0014015; P:positive regulation of gliogenesis; ISO:RGD.
DR   GO; GO:0031643; P:positive regulation of myelination; IMP:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; IEP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006368; P:transcription elongation by RNA polymerase II; IDA:RGD.
DR   CDD; cd22031; HMG-box_SoxE; 1.
DR   Gene3D; 1.10.30.10; High mobility group box domain; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR022151; Sox_N.
DR   InterPro; IPR050917; SOX_TF.
DR   PANTHER; PTHR45803; SOX100B; 1.
DR   PANTHER; PTHR45803:SF6; TRANSCRIPTION FACTOR SOX-10; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12444; Sox_N; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; HMG-box; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Cytoplasm; DNA-binding; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..466
FT                   /note="Transcription factor SOX-10"
FT                   /id="PRO_0000048748"
FT   DNA_BIND        104..172
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   REGION          1..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          62..102
FT                   /note="Dimerization (DIM)"
FT                   /evidence="ECO:0000250|UniProtKB:P56693"
FT   REGION          160..198
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          213..275
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..310
FT                   /note="Transactivation domain (TAM)"
FT                   /evidence="ECO:0000250|UniProtKB:P56693"
FT   REGION          353..466
FT                   /note="Transactivation domain (TAC)"
FT                   /evidence="ECO:0000250|UniProtKB:P56693"
FT   REGION          355..375
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          433..466
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        53..67
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        160..184
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        251..266
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        357..375
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        436..466
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         24
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56693"
SQ   SEQUENCE   466 AA;  50039 MW;  094B0C5E42D83454 CRC64;
     MAEEQDLSEV ELSPVGSEEP RCLSPSSAPS LGPDGGGGGS GLRASPGPGE LGKVKKEQQD
     GEADDDKFPV CIREAVSQVL SGYDWTLVPM PVRVNGASKS KPHVKRPMNA FMVWAQAARR
     KLADQYPHLH NAELSKTLGK LWRLLNESDK RPFIEEAERL RMQHKKDHPD YKYQPRRRKN
     GKAAQGEAEC PGGETDQGGA AAIQAHYKSA HLDHRHPEEG SPMSDGNPEH PSGQSHGPPT
     PPTTPKTELQ SGKADPKRDG RSLGEGGKPH IDFGNVDIGE ISHEVMSNME TFDVTELDQY
     LPPNGHPGHV GSYSAAGYGL SSALAVASGH SAWISKPPGV ALPTVSPPAV DAKAQVKTET
     TGPQGPPHYT DQPSTSQIAY TSLSLPHYGS AFPSISRPQF DYSDHQPSGP YYGHAGQASG
     LYSAFSYMGP SQRPLYTAIS DPSPSGPQSH SPTHWEQPVY TTLSRP
//
